ATLAS / Macro Radar / Reporting / ELVN

Enliven Therapeutics, Inc. (ELVN) reporting calendar

Enliven Therapeutics, Inc. files periodic reports with the SEC as ELVN on Nasdaq. Atlas tracks 25 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
27 Jul 2026 – 30 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
25

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001193125-26-211982
10-K31 Dec 20253 Mar 202662 days0001193125-26-088232
10-Q30 Sep 202512 Nov 202543 days0001193125-25-277619
10-Q30 Jun 202513 Aug 202544 days0001193125-25-179845
10-Q31 Mar 202514 May 202544 days0000950170-25-071412
10-K31 Dec 202413 Mar 202572 days0000950170-25-038758
10-Q30 Sep 202413 Nov 202444 days0000950170-24-126332
10-Q30 Jun 202413 Aug 202444 days0000950170-24-096239
10-Q31 Mar 202414 May 202444 days0000950170-24-059573
10-K31 Dec 202314 Mar 202474 days0000950170-24-031495
10-Q30 Sep 20239 Nov 202340 days0000950170-23-062080
10-Q30 Jun 202310 Aug 202341 days0000950170-23-041349
10-Q31 Mar 202311 May 202341 days0000950170-23-021262
10-K31 Dec 202210 Feb 202341 days0001564590-23-001729
10-Q30 Sep 202225 Oct 202225 days0001564590-22-035098
10-Q30 Jun 20223 Aug 202234 days0001564590-22-027795
10-Q31 Mar 20226 May 202236 days0001564590-22-018458
10-K31 Dec 202115 Mar 202274 days0001564590-22-010216
10-Q30 Sep 20219 Nov 202140 days0001564590-21-055446
10-Q30 Jun 20216 Aug 202137 days0001564590-21-041904
10-Q31 Mar 202111 May 202141 days0001564590-21-026283
10-K31 Dec 20205 Mar 202164 days0001564590-21-011098
10-Q30 Sep 20205 Nov 202036 days0001564590-20-050867
10-Q30 Jun 202014 Aug 202045 days0001564590-20-040173
10-Q31 Mar 20207 May 202037 days0001564590-20-022393

Source: SEC EDGAR company submissions for CIK 0001672619. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.